| Code | CSB-RA023375MB1HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is developed as a research-grade biosimilar to PMC-403, targeting TEK (TIE2), a receptor tyrosine kinase critical for vascular development and angiogenesis. TEK is primarily expressed on vascular endothelial cells and mediates angiopoietin signaling, regulating blood vessel maturation, stability, and remodeling. Through its interaction with angiopoietin-1 and angiopoietin-2, TEK controls endothelial cell survival, migration, and vascular permeability. Dysregulation of TEK signaling is implicated in various pathological conditions, including tumor angiogenesis, diabetic retinopathy, cardiovascular diseases, and hereditary vascular malformations.
PMC-403 is an established research antibody used to investigate TEK expression patterns and function in vascular biology studies. This biosimilar provides researchers with a reliable tool for exploring TEK-mediated signaling pathways, examining endothelial cell biology, and studying angiogenic processes in disease models. The antibody facilitates investigations into vascular development, tumor microenvironment dynamics, and therapeutic targeting strategies for angiogenesis-related disorders.
There are currently no reviews for this product.